RemeGen Co., Ltd.

OTCPK:REGM.F Stock Report

Market Cap: US$8.9b

RemeGen Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:REGM.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 May 26SellUS$1,732,676China Universal Asset Management Company Ltd.Company160,000US$10.83
22 Apr 26BuyUS$1,147,567China Universal Asset Management Company Ltd.Company79,000US$14.53
31 Mar 26SellUS$2,278,723Weidong WangIndividual186,000US$12.25
23 Jan 26SellUS$624,893Weidong WangIndividual53,000US$11.79
22 Jan 26SellUS$29,455,520Jianmin FangIndividual2,500,000US$11.78
21 Jan 26SellUS$585,732Weidong WangIndividual47,500US$12.33
16 Jan 26SellUS$249,248Weidong WangIndividual20,000US$12.46
13 Jan 26SellUS$792,212Weidong WangIndividual60,000US$13.20
05 Dec 25SellUS$115,705Weidong WangIndividual10,000US$11.57
27 Nov 25SellUS$1,835,586Weidong WangIndividual160,000US$11.47
26 Nov 25SellUS$663,427Weidong WangIndividual60,000US$11.06
25 Nov 25SellUS$1,947,162BlackRock, Inc.Company185,500US$10.50
24 Nov 25BuyUS$49,168,159BlackRock, Inc.Company4,613,045US$10.66
24 Nov 25SellUS$655,407Weidong WangIndividual60,000US$10.92
30 Sep 25SellUS$308,458Weidong WangIndividual20,000US$15.42
29 Sep 25SellUS$1,394,170Weidong WangIndividual100,000US$13.94
15 Sep 25SellUS$295,682Weidong WangIndividual20,000US$14.78
11 Sep 25SellUS$141,222Weidong WangIndividual10,000US$14.12
09 Sep 25SellUS$417,317Weidong WangIndividual30,000US$13.91
01 Sep 25SellUS$255,000Weidong WangIndividual20,000US$12.75
29 Aug 25SellUS$903,385Weidong WangIndividual72,000US$12.55
25 Aug 25SellUS$2,011,158Weidong WangIndividual180,000US$11.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of REGM.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Individual Insiders66,896,20911.9%
Institutions146,859,63026.2%
Employee Share Scheme148,873,47426.6%
General Public197,340,97735.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 61.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.6%
RemeGen Co., Ltd , ESOP
148,873,474US$2.4b0%no data
10.6%
Jianmin Fang
59,563,320US$949.8m0%no data
3.59%
China Universal Asset Management Company Ltd.
20,113,752US$320.7m45.5%0.71%
2.55%
PAG Growth Capital
14,263,276US$227.4m0%100.0%
2.21%
Allianz Asset Management GmbH
12,374,848US$197.3m0%0.13%
1.81%
BlackRock, Inc.
10,161,257US$162.0m-6.82%no data
1.35%
Lapam Capital
7,538,084US$120.2m0%58.78%
1.22%
Vanguard Capital Management, LLC
6,832,090US$108.9m0.38%no data
1.17%
Bank of China Investment Management Co., Ltd.
6,541,197US$104.3m0%2.34%
1.15%
Weidong Wang
6,444,379US$102.8m5.74%no data
1.02%
Maxwealth Fund Management Co., Ltd
5,705,936US$91.0m0%0.46%
1.01%
HuaAn Fund Management Company Ltd.
5,678,714US$90.6m0%0.25%
0.97%
GF Fund Management Co., Ltd.
5,413,079US$86.3m0%0.12%
0.94%
Yinhua Fund Management Co., Ltd.
5,238,287US$83.5m0%0.33%
0.93%
Wanjia Asset Management Co., Ltd.
5,225,000US$83.3m0%0.87%
0.89%
ICBC Credit Suisse Fund Management Co., Ltd
4,976,552US$79.4m0%0.28%
0.65%
E Fund Management Co., Ltd.
3,618,608US$57.7m0.05%0.06%
0.61%
China Merchants Fund Management Company Ltd.
3,401,923US$54.2m0%0.15%
0.55%
Morgan Stanley
3,069,909US$49.0m0%no data
0.32%
China Southern Asset Management Co., Ltd.
1,796,274US$28.6m0%0.05%
0.32%
Vanguard Fiduciary Trust Company
1,775,341US$28.3m0.59%no data
0.3%
Penghua Fund Management Co., Ltd.
1,706,943US$27.2m0%0.09%
0.3%
Bosera Asset Management Co., Ltd.
1,706,812US$27.2m0%0.12%
0.26%
China Asset Management Co. Ltd.
1,454,289US$23.2m0%0.02%
0.21%
Tianhong Asset Management Co., Ltd.
1,202,178US$19.2m0%0.1%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/08 15:09
End of Day Share Price 2026/06/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RemeGen Co., Ltd. is covered by 29 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhishun SiuCCB International Securities Limited
Shun Kei LawCCB International Securities Limited
Jin ZhangChina International Capital Corporation Limited